Both in Biotechnology
Calidi Biotherapeutics vs AIM ImmunoTech
Over the past year CLDI returned −97.1% and AIM returned −93.5%; their daily moves had a correlation of 0.02.
CLDI −97.1% AIM −93.5%Growth of $1, one year, split-adjusted
| Metric | CLDI | AIM |
|---|---|---|
| Price | $0.7018 | $0.1650 |
| Market cap | $1.8M | $6.6M |
| Today | +6.33% | −0.72% |
| 1 month | −35.0% | −4.9% |
| 6 months | −79.0% | −68.5% |
| Year to date | −96.3% | −85.4% |
| 1 year | — | −93.7% |
| Revenue growth (YoY) | — | +4.0% |
| Gross margin | — | 80.8% |
| Net margin | — | −26876.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 69.3× |
| Net cash | $3.1M | $6.3M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 72.2% |
| Short % of float | 0.9% | 3.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).